Coral Calcium's Effect on Bone Density in Postmenopausal Women With and Without Ibandronate

NCT04321837 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-05-09

No results posted yet for this study

Summary

This study will investigate the effect of coral calcium complex supplementation on BMD of osteoporotic individuals either when used alone or in combination with ibandronate. Ibandronate alone will also be tested in comparison to coral calcium supplementation alone or in combination.

Conditions

  • Osteoporosis, Postmenopausal

Interventions

DIETARY_SUPPLEMENT

Coral Complex 3

Coral-derived calcium supplement fortified with vitamin D3

DRUG

Ibandronate

Bisphosphonate

DIETARY_SUPPLEMENT

Vitamin D3

Oral vitamin D3

Sponsors & Collaborators

  • University of California, Irvine

    collaborator OTHER
  • Osteoporosis Center of Armenia

    collaborator UNKNOWN
  • Columbia University

    lead OTHER

Principal Investigators

  • John P Bilezikian, MD, PhD · Columbia University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-02-05
Primary Completion
2023-03-13
Completion
2023-03-13

Countries

  • Armenia

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04321837 on ClinicalTrials.gov